Abstract I first became curious about Ozempic not because of its weight‑loss effects but because of how differently it seemed to act in different people. For some, it quieted a lifetime of cravings; for others, it did almost nothing. For a few, it caused unexpected vision problems. That variation, I thought, must hold a clue to something deeper. In this paper, I argue that drugs like semaglutide work by a principle I call threshold restoration: they restore normal function only when a specific physiological threshold has been crossed—whether that is high blood sugar, excessive appetite, or chronic brain inflammation. They do not enhance already normal systems. This simple idea explains a surprising range of observations: why the drug is so effective in metabolic disease but not in healthy people, why it reduces Alzheimer's risk in diabetics but fails to help those with advanced dementia, and why it can both harm and protect the eye. I develop the framework through three interconnected domains. First, I look at the brain's reward system and argue that dopamine acts as an energy currency. In obesity, the brain's craving for dopamine becomes disconnected from actual energy needs, leading to overeating. Semaglutide recalibrates that link. Second, I examine Alzheimer's disease, proposing that chronic metabolic stress drives the brain to overproduce amyloid precursor protein (APP) as part of an inflammatory response. By reducing that stress, semaglutide lowers APP and amyloid—but only before irreversible damage sets in. Third, I turn to the eye as a sentinel of cerebral energy imbalance, explaining why rapid metabolic shifts can trigger rare vision problems while long‑term stability protects against macular degeneration and glaucoma. The framework offers practical guidance for patient selection, slow dose titration, and monitoring. It also suggests that these drugs are not "wonder drugs" but precise tools for restoring balance where balance has been lost.
Building similarity graph...
Analyzing shared references across papers
Loading...
Sameer Rohatgi
Building similarity graph...
Analyzing shared references across papers
Loading...
Sameer Rohatgi (Tue,) studied this question.
www.synapsesocial.com/papers/69d893eb6c1944d70ce04d58 — DOI: https://doi.org/10.5281/zenodo.19448588